Hudson Bay Capital Management
CLSD

Hudson Bay Capital Management’s Clearside Biomedical CLSD Stock Holding History

Hudson Bay Capital Management’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,227
Closed -$16.9K – 1423
2025
Q1 		$16.9K Buy
+1,227
New +$17.6K ﹤0.01% 1233

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hudson Bay Capital Management's CLSD Position: Q2 2025 in Review

Hudson Bay Capital Management sold out of Clearside Biomedical (CLSD) in Q2 2025, closing a stake of 1,227 shares — an estimated $16.9K sold.

Hudson Bay Capital Management first reported a position in CLSD in Q1 2025 and held it in 1 quarter. The position peaked at $16.9K in Q1 2025. 44 funds tracked by Wall St. Rank hold CLSD as of Q2 2025.

  • Hudson Bay Capital Management reported no remaining Clearside Biomedical position as of Q2 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 1,227 Clearside Biomedical shares in Q2 2025, an estimated $16.9K.
  • Hudson Bay Capital Management first reported a position in Clearside Biomedical in Q1 2025 and held it in 1 quarter.
  • Hudson Bay Capital Management's Clearside Biomedical position peaked at $16.9K in Q1 2025.
  • 44 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2025.

Based on Hudson Bay Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.